The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1305
A Diuretic for Initial Treatment of Hypertension?
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Effective treatment of hypertension can prevent organ damage and death. The choice of drugs for initial treatment continues to be controversial.1

ALLHAT — In the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), a randomized, double-blind, 4.9-year study in more than 30,000 older (≥55 years) high-risk hypertensive patients, therapy based on the thiazide-type diuretic chlorthalidone 12.5-25 mg/day (used as the initial drug, but one or 2 drugs could be added) was as effective as the ACE inhibitor lisinopril (Zestril, Prinivil, and others) or the dihydropyridine calciumchannel blocker amlodipine (Norvasc, and others) in preventing the primary endpoint of fatal coronary heart disease or nonfatal myocardial infarction.2

For the secondary endpoint of all-cause mortality, there was no difference between the 3 drugs. ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: A Diuretic for Initial Treatment of Hypertension?
Article code: 1305a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian